Lobular neoplasia of the breast: 68 Years on

Pathology

Volumn 41, Issue 1, 2009, Pages 28-35

  Ho, Bernard Chi Shern ^a   Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Atypical lobular hyperplasia; Lobular carcinoma in situ; Lobular neoplasia; Review

Indexed keywords

ASPIRATION BIOPSY; BREAST TUMOR; CANCER CELL; CANCER DIAGNOSIS; CELL STRUCTURE; CLINICAL FEATURE; CYTODIAGNOSIS; EXCISION; HUMAN; IMMUNOHISTOCHEMISTRY; LOBULAR NEOPLASIA; MICROSCOPY; NOMENCLATURE; RADIODIAGNOSIS; REVIEW;

EID: 57749087882     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802563494     Document Type: Article

References (31)

1. Foote FWJ, Stewart FW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol 1941; 17: 491-6.
2. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231-73.
3. Rosen PP. Rosen's Breast Pathology. Philadelphia: Lippincott-Raven, 1997.
4. Page DL, Anderson TJ, editors. Diagnostic Histopathology of the Breast. New York: Churchill Livingstone, 1987.
5. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
6. Haagensen CD, Lane N, Lattes R, et al. Lobular neoplasia (so called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-69.
7. Tavassoli FA. Lobular neoplasia (lobular carcinoma in situ). In: Tavassoli FA, editor. Pathology of the Breast. 2nd ed. Norwalk, CT: Appleton and Lange, 1999; 263-91.
8. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007; 31: 417-26.
9. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002; 15: 1044-50.
10. Jacobs TW, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 25: 229-36.
11. Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 2007; 31: 427-37.
12. Dabbs DJ, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter GJ. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2007; 15: 260-6.
13. Bratthauer GL, Moinfar F, Stamatakos MD, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-7.
14. Buerger H, Simon R, Schäfer KL, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000; 53: 118-21.
15. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998; 58: 4721-7.
16. Lakhani SR, Collins N, Sloane JP, Stratton MR. Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 1995; 48: M74-8.
17. Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005; 18: 741-51.
18. Shelley Hwang E, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562-72.
19. Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131-3.
20. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000; 24: 1650-6.
21. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma in situ of the breast: role of comprehensive molecular pathology in characterization of an entitiy. J Pathol 2005; 207: 1-13.
22. Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003; 16: 674-8.
23. O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy: what is the clinical significance? Clin Radiol 2001; 56: 216-20.
24. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high risk lesions of the breast diagnosed at stereotactic core needle biopsy: clinical importance. Radiology 2000; 216: 831-7.
25. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in-situ at core-needle breast biopsy.Radiology 2001; 218: 503-9.
26. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on core biopsy. Arch Pathol Lab Med 2002; 126: 697-701.
27. Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med 2008; 132: 979-83.
28. Pacelli A, Rhodes DJ, Amrami KK, et al. Outcome of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases. Am J Clin Pathol 2001; 116: 591-2.
29. Middleton LP, Shakeitha G, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?Mod Pathol 2003; 16: 120-9.
30. Renshaw AE, Cartagena N, Derhagopian RP. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002; 117: 797-9.
31. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 2006; 30: 1445-53.